Created by the Conference Forum, in collaboration with the Society for Immunotherapy of Cancer, this year's Immuno-Oncology 360° conference will take place from Feb 26 - 28, 2019 at the Crowne Plaza Times Square in New York City.
IO360 ̊ convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 6th annual Immuno-Oncology 360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features more than 80 time sensitive IO topics, over 500 senior level thought leaders and includes over 10 hours of networking.
New for 2020:
- Cell & Gene Therapy Day - A full day on February 27th dedicated to Cell & Gene Therapy for Solid Tumors. Chaired by Dr Aiman Shalabi, GSK. Keynotes, Cornerstone and Notable Speakers include Dr Carl June*, UPenn, Dr Crystal Mackall, Stanford University, Dr Arie Belldegrun, Allogene, Dr Peter Marks, FDA, Dr Stephanie Goff*, NCI, amongst many more.
*Indicates a SITC member.
2020 Plenary Topics
- Discovery/Preclinical Science
- Imaging Aspects
- Clinical Operations
- Business Developments
- Translational Science
- Emerging Biomarkers
- IO Novel Technologies
- AI & Machine Learning
- Clinical Developments
Use the code SITC20 for a 20% discount.
For more information please visit: www.io360summit.com